The reimbursement for expensive medicines: stakeholder perspectives on the SMA medicine nusinersen and the Dutch Coverage Lock policy

BACKGROUND: The reimbursement for expensive medicines poses a growing challenge to healthcare worldwide. In order to increase its control over the costs of medicines, the Dutch government introduced the Coverage Lock (CL) policy in 2015. The CL postpones decisions regarding reimbursement of expensiv...

Descripción completa

Detalles Bibliográficos
Autores principales: Scheijmans, Féline E. V., Zomers, Margot L., Fadaei, Sina, Onrust, Marthe R., van der Graaf, Rieke, Delden, Johannes J. M. van, van der Pol, W. Ludo, van Thiel, Ghislaine J. M. W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9636634/
https://www.ncbi.nlm.nih.gov/pubmed/36333803
http://dx.doi.org/10.1186/s12913-022-08690-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9636634/
https://www.ncbi.nlm.nih.gov/pubmed/36333803
http://dx.doi.org/10.1186/s12913-022-08690-z

Ejemplares similares